Brodalumab Subcutaneous and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Brodalumab Subcutaneous and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brodalumab
Brand name: Siliq
Synonyms: Brodalumab
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brodalumab Subcutaneous-Lithium ER
- Brodalumab Subcutaneous-Lithium Oral Solution
- Brodalumab Subcutaneous-Lithium Salts
- Brodalumab Subcutaneous-Lithium Syrup and Oral Solution
- Brodalumab Subcutaneous-Lithobid
- Brodalumab Subcutaneous-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Brodspec
- Lithium Controlled-Release and Extended-Release Tablets-Brom Mal Phenyl HCl Dex HBr
- Lithium Controlled-Release and Extended-Release Tablets-Bromaline
- Lithium Controlled-Release and Extended-Release Tablets-Bromaline DM
- Lithium Controlled-Release and Extended-Release Tablets-Bromatan Plus
- Lithium Controlled-Release and Extended-Release Tablets-Bromatan-DM